|
|
Title | Creator | Description | Identifier |
1 |
|
Clinical Outcomes of Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG)-related optic neuritis | John Chen, Eoin Flanagan, Alfonso Lopez Chiriboga, Jim Fryer, Jiraporn Jitprapaikulsan, Jacqueline Leavitt, Jeffrey Bennett,; Victoria Pelak, Collin McClelland, Michael Lee, Ore-ofe Adesina, Yanjun Chen, Gregory Van Stavern, Eric Eggenberger, Paul; Brazis, Dean Wingerchuk, Marie Acierno, Sean Pittoc... | Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a biomarker of optic neuritis whose phenotype is still being; characterized. We report the largest cohort to date of MOG-IgG seropositive optic neuritis patients. | 20180306_nanos_sciplatform2_01-1 |
2 |
|
Clinical Outcomes of Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG)-related optic neuritis | John Chen, Eoin Flanagan, Alfonso Lopez Chiriboga, Jim Fryer, Jiraporn Jitprapaikulsan, Jacqueline Leavitt, Jeffrey Bennett,; Victoria Pelak, Collin McClelland, Michael Lee, Ore-ofe Adesina, Yanjun Chen, Gregory Van Stavern, Eric Eggenberger, Paul; Brazis, Dean Wingerchuk, Marie Acierno, Sean Pittoc... | Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a biomarker of optic neuritis whose phenotype is still being; characterized. We report the largest cohort to date of MOG-IgG seropositive optic neuritis patients. | 20180306_nanos_sciplatform2_01-2 |